Authors
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Kara Watts, MD, envisions future trends in focal therapy for prostate cancer"There's a number of emerging modalities in the primary focal ablation space that are in trial at this time," says Kara L. Watts, MD.
Latest:
John Gore, MD, on bladder preservation in muscle–invasive bladder cancer“In this well-selected patient population, it is possible to treat with systemic therapy alone," says John L. Gore, MD, MS.
Latest:
Expert Perspectives on the VIOLETTE Study and Future Directions in Prostate Cancer ResearchAmir H. Lebastchi, MD, provides perspectives on the VIOLETTE study and underscores the importance of future head-to-head trials to gain a deeper understanding of various treatment approaches.
Latest:
MRI/TRUS fusion-guided biopsy using UroNavPinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.
Latest:
MRI/TRUS fusion-guided biopsy using UroNavPinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.
Latest:
Focal therapy’s future in prostate cancer is bright, says Arvin George, MD"When we look at focal therapy in general, the better we're able to see, localize, identify and risk stratify prostate cancers, the better we're able to treat them and offer more personalized and focal treatments," says Arvin George, MD.
Latest:
UroView: Gallium 68 PSMA–Targeted PET Imaging in Prostate Cancer: Staging and OutcomesThis article features insights from Phillip Kuo, MD, PhD, and Andre Abreu, MD, on gallium 68 PSMA-targeted PET imaging in prostate cancer.
Latest:
New developments may change treatment of OAB"New treatments (pharmacological and device based) are currently in development to expand our OAB armamentarium," write Nathan Chertack, MD, and Gary Lemack, MD.
Latest:
New developments may change treatment of OAB"New treatments (pharmacological and device based) are currently in development to expand our OAB armamentarium," write Nathan Chertack, MD, and Gary Lemack, MD.
Latest:
Artificial intelligence is the new ghost author in urological research“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.
Latest:
Acute-care urology during the pandemic: Lessons learned"The goal of this narrative is to share details and lessons learned during our on-call urology coverage in the midst of the current pandemic so we can help others by informing planning," write Alexander Small, MD, and Rich Matulewicz, MD.
Latest:
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBCMatthew D. Galsky, MD, discusses how urologists should approach patient selection for perioperative durvalumab plus chemotherapy based on eligibility criteria for the NIAGARA trial.
Latest:
Addition to avelumab to best supportive care after firstline chemo improves OS in advanced urothelial CaAvelumab (Bavencio) as a maintenance treatment after chemotherapy significantly extended overall survival in patients with advanced urothelial cancer, according to findings from thephase III JAVELIN Bladder 100 trial.
Latest:
Management of UTUC using a kidney-sparing approachAdvances in endourology have made kidney-sparing treatments a viable treatment option.
Latest:
Robotics in GU oncology: Current status, future directionsThe breadth of applications will widen as the number of new platforms grows, according Joshua Calvert, MD, MPH.
